In focus · trending topic

Personalized Medicine

36 stories · following the connections

Tempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer Patients

By Nasdaq OMXJan 25, 2018, 3:30 PM UTC

ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial

By Nasdaq OMXJan 8, 2018, 1:31 PM UTC

Tempus and Vanderbilt-Ingram Cancer Center Announce Data Initiative to Improve Outcomes for Cancer Patients

By Nasdaq OMXJan 4, 2018, 4:00 PM UTC

ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting

By Nasdaq OMXNov 16, 2017, 1:30 PM UTC

Tempus Announces Latest Immunotherapy Project

By Nasdaq OMXNov 15, 2017, 3:15 PM UTC

Tempus and Sanford Health Collaborate on Personalized Medicine Initiative

By Nasdaq OMXNov 1, 2017, 2:15 PM UTC

Tempus Unveils Tempus xT, 595 Gene Panel Aimed at Empowering Data-Driven Cancer Care

By Nasdaq OMXOct 19, 2017, 2:30 PM UTC

Tempus Announces $130M Raised

By Nasdaq OMXSep 25, 2017, 1:00 PM UTC